Applied Data Research Analyzes Therapeutic, Economic and Compliance Factors Driving Growth
(Nashua, NH) - The ability of patients to reliably and consistently self-administer injectable drugs has become a critical element in healthcare planning and disease management of chronic conditions. By combining the therapeutic potential of biological drugs with patient-friendly delivery devices that are increasingly designed for a specific drug delivery application, drug delivery pens are creating a paradigm shift in patient care for the long-term management of intractable and refractory ailments. Many of these therapeutic targets represent significant and growing healthcare markets, and include diabetes, anemia, HCV, and several autoimmune conditions.
In spite of the significantly premium unit cost of the current generation of pen injectors relative to disposable syringes, the high cost of recombinant drugs and the savings associated with improved patient compliance and avoiding periodic caregiver visits for lifelong conditions make the overall economics of combination pen/drug devices favorable and in some cases compelling. Autoinjectors that work with prefilled disposable syringes are also gaining interest. The recent introduction of fully disposable, pre-assembled devices will experience growth by filling an important market niche.
Custom pens designs are now the rule rather than the exception. Customized pens have become a big part of therapeutic product branding in the direct-to-consumer marketing world. By packaging therapeutic drugs in distinctive devices with ergonomic and usability features, pharmaceutical companies are striving not only differentiate their products from the competition, but to increase user acceptance and patient compliance.
These and other conclusions are the subject of a comprehensive report. The report documents and analyzes the results of a recent survey of the pen and autoinjector drug delivery sector conducted by Applied Data Research.
More information is also available at www.applieddata.org .
About Applied Data
Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Contact:
Greg Stone
Voice: 603-595-6225
www.applieddata.org
Source: Applied Data Research
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
